Treatment of Gingival Overgrowth Induced by Manidipine Administration. A Case Report
Autor: | Masaki Iwakura, Hidetoshi Shimauchi, Seizaburo Sakamoto, Kyoko Ikawa, Motohide Ikawa |
---|---|
Rok vydání: | 2002 |
Předmět: |
Adult
Dihydropyridines medicine.medical_specialty Periodontal examination medicine.medical_treatment Bleeding on probing Carteolol Hydrochloride Gastroenterology Piperazines Gingivectomy Root Planing Angina Manidipine Scaling and root planing Internal medicine Humans Periodontal Pocket Medicine Carteolol Saliva Antihypertensive Agents Nitrobenzenes Gingival Overgrowth business.industry Dental Plaque Index Calcium Channel Blockers Oral Hygiene medicine.disease Surgery Sjogren's Syndrome Hypertension Dental Scaling Denture Partial Fixed Periodontics Female Periodontal Index medicine.symptom business medicine.drug |
Zdroj: | Journal of Periodontology. 73:115-122 |
ISSN: | 1943-3670 0022-3492 |
DOI: | 10.1902/jop.2002.73.1.115 |
Popis: | It is well known that severe gingival overgrowth (GO) is induced in patients taking certain calcium channel blockers (CCB) for the treatment of hypertension, angina pectoris, and other diseases. No case has been reported to date of severe GO induced by manidipine hydrochloride (manidipine), a second generation CCB. This case report describes severe GO induced by manidipine in a female patient (43 years old) with hypertension and Sjögren syndrome (SS). The patient was administered manidipine and carteolol hydrochloride (carteolol) as antihypertensive drugs, together with bromhexine hydrochloride for the treatment of SS.At the initial periodontal examination, probing depth (PD, average 4.83 mm), plaque control record (PCR, 84.3%), bleeding on probing (BOP, 100%), and gingival overgrowth index (GOI, 2.42) were assessed. The patient received periodontal treatment without cessation or replacement of the causative drug. Initial treatment included oral hygiene and scaling and root planing (SRP) under local anesthesia. As corrective therapy, remaining pockets were surgically removed and fixed bridges placed to establish proper occlusion.Obvious reductions in PCR (10.0%), PD (1.93 mm), GOI (0.02), and BOP (4.7%), together with a disappearance of GO, were obtained. Salivary secretion was increased after the periodontal and prosthetic treatments. Histological features were similar to those of nifedipine-induced GO.This case indicated that manidipine may act as a potent inducer of severe GO, and that conventional periodontal treatments without a major change of the causative drugs can yield satisfactory clinical responses. |
Databáze: | OpenAIRE |
Externí odkaz: |